Susan Romanus

chief compliance officer at ADC Therapeutics - Epalinges, Vaud, CH

Susan Romanus's Colleagues at ADC Therapeutics
Kelly Egan

Hematology Therapeutic Specialist

Contact Kelly Egan

Jennifer McMillan

Hematology Therapeutic Specialist

Contact Jennifer McMillan

Jan Karoll

Hematology Therapeutic Specialist

Contact Jan Karoll

Lauren Benedict

clinical operations manager

Contact Lauren Benedict

Hoa Chu

Senior Medical Science Liaison

Contact Hoa Chu

View All Susan Romanus's Colleagues
Susan Romanus's Contact Details
HQ
+41 21 653 02 00
Location
Company
ADC Therapeutics
Susan Romanus's Company Details
ADC Therapeutics logo, ADC Therapeutics contact details

ADC Therapeutics

Epalinges, Vaud, CH • 325 Employees
BioTech/Drugs

ADC Therapeutics is a commercial-stage global pioneer in the field of antibody drug conjugates (ADCs). Our goal is to be a leading ADC company that transforms the lives of those impacted by cancer. To achieve this, we are focused on unlocking the potential value of our robust ADC portfolio across two pillars of growth: hematology and solid tumors. We are a pioneer in the ADC field with specialized end-to-end capabilities unique to ADCs including a validated technology platform, a growing next-generation research & development toolbox and a proven track record that includes an approved and marketed product. We aim to expand our portfolio and accelerate the development of our pipeline through targeted investments and in collaboration with strategic partners. In this way, we plan to pursue multiple targets in parallel, enabling us to prioritize and ensure disciplined capital allocation strategy while advancing the most promising candidates in both hematology and solid tumors. Our CD19-directed ADC ZYNLONTA® (loncastuximab tesirine-lpyl) received accelerated approval by the FDA and conditional approval from the European Commission for the treatment of relapsed or refractory diffuse large B-cell lymphoma after two or more lines of systemic therapy. ZYNLONTA is also in development in combination with other agents and in earlier lines of therapy. Founded in 2011, ADC Therapeutics is based in Lausanne, Switzerland, with operations in London and New Jersey. Our highly skilled global team is committed to confronting cancer with the full potential of our science and transforming the treatment paradigm for patients with cancer. For more information, please visit https://www.adctherapeutics.com/.

Cancer Research Targeted Cancer Therapies Solid Tumors Molecular Oncology Biopharmaceuticals Healthcare Innovation Clinical Trials Biotechnology
Details about ADC Therapeutics
Frequently Asked Questions about Susan Romanus
Susan Romanus currently works for ADC Therapeutics.
Susan Romanus's role at ADC Therapeutics is chief compliance officer.
Susan Romanus's email address is ***@adctherapeutics.com. To view Susan Romanus's full email address, please signup to ConnectPlex.
Susan Romanus works in the BioTech/Drugs industry.
Susan Romanus's colleagues at ADC Therapeutics are Kelly Egan, Jennifer McMillan, Jan Karoll, Lauren Benedict, Hoa Chu, Kimberly Brunelli, Ruiqi Hao and others.
Susan Romanus's phone number is +41 21 653 02 00
See more information about Susan Romanus